Integrative Oncology Outcomes Study in Breast Cancer
Completed
Conditions studied: Breast Cancer
In brief
This NIH-NCCAM funded epidemiologic research is being conducted as an observational prospective case-control study of the use of Complementary and Alternative Medicine (CAM) and Integrated Oncology (IO) and their effects on breast cancer patients in community settings. Hypothesis: IO services improve patients' quality of life and decrease cancer recurrence rates in breast cancer patients as compared to women with similar disease states and prognoses who do not receive IO care, and may or may not use CAM treatment on their own.
Key facts
- Study ID
- NCT01366248
- Run by
- Bastyr University
- People needed
- 750
- Starts
- 2010-08-01
- Expected to finish
- 2017-12-31
- Last updated by the study team
- 2018-03-22
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Red Cedar Wellness Center — Bellevue, Washington, United States
- Bastyr Integrative Oncology Research Center — Kenmore, Washington, United States
- Seattle Integrative Oncology at Providence Integrative Cancer Care — Lacey, Washington, United States
- Seattle Cancer Treatment & Wellness Center — Renton, Washington, United States
- Seattle Integrative Oncology at Institute of Complementary Medicine — Seattle, Washington, United States
- Tree of Health Integrative Medicine — Woodinville, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.